Latest Insider Transactions at Soc Telemed, Inc. (TLMD)
This section provides a real-time view of insider transactions for Soc Telemed, Inc. (TLMD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SOC Telemed, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SOC Telemed, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 06
2022
|
Barbara Peterson Byrne |
SELL
Sale (or disposition) back to the issuer
|
Direct |
58,387
-100.0%
|
$175,161
$3.0 P/Share
|
|
Apr 06
2022
|
Thomas J. Carella |
SELL
Sale (or disposition) back to the issuer
|
Direct |
90,591
-100.0%
|
$271,773
$3.0 P/Share
|
|
Apr 06
2022
|
Gyasi C. Chisley |
SELL
Sale (or disposition) back to the issuer
|
Direct |
44,150
-100.0%
|
$132,450
$3.0 P/Share
|
|
Apr 06
2022
|
Christopher M. Gallagher Chief Executive Officer |
SELL
Other acquisition or disposition
|
Indirect |
401,243
-100.0%
|
-
|
|
Apr 06
2022
|
Christopher M. Gallagher Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct |
3,316,679
-100.0%
|
-
|
|
Apr 06
2022
|
Joseph P Greskoviak |
SELL
Sale (or disposition) back to the issuer
|
Direct |
79,185
-100.0%
|
$237,555
$3.0 P/Share
|
|
Apr 06
2022
|
Robert Jason Hallock Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
15,677
-100.0%
|
$47,031
$3.0 P/Share
|
|
Apr 06
2022
|
Eunice Kim General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
22,168
-100.0%
|
$66,504
$3.0 P/Share
|
|
Apr 06
2022
|
Amr Kronfol |
SELL
Sale (or disposition) back to the issuer
|
Direct |
101,325
-100.0%
|
$303,975
$3.0 P/Share
|
|
Apr 06
2022
|
Anne Mc George |
SELL
Sale (or disposition) back to the issuer
|
Direct |
58,387
-100.0%
|
$175,161
$3.0 P/Share
|
|
Apr 06
2022
|
David Mikula Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
496,576
-100.0%
|
$1,489,728
$3.0 P/Share
|
|
Apr 06
2022
|
Steven J Shulman |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,112,291
-100.0%
|
$3,336,873
$3.0 P/Share
|
|
Apr 06
2022
|
Warburg Pincus & Co. Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
67,749,930
-100.0%
|
$203,249,790
$3.0 P/Share
|
|
Apr 01
2022
|
Robert Jason Hallock Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,491
-7.32%
|
$12,982
$2.98 P/Share
|
|
Dec 20
2021
|
David Mikula Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
450,000
+32.22%
|
-
|
|
Dec 20
2021
|
Christopher M. Gallagher Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,080,000
+19.72%
|
-
|
|
Jun 03
2021
|
Barbara Peterson Byrne |
BUY
Grant, award, or other acquisition
|
Direct |
21,067
+26.51%
|
-
|
|
Jun 03
2021
|
Thomas J. Carella |
BUY
Grant, award, or other acquisition
|
Direct |
21,067
+18.87%
|
-
|
|
Jun 03
2021
|
Joseph P Greskoviak |
BUY
Grant, award, or other acquisition
|
Direct |
25,982
+13.97%
|
-
|
|
Jun 03
2021
|
Amr Kronfol |
BUY
Grant, award, or other acquisition
|
Direct |
21,067
+17.21%
|
-
|
|
Jun 03
2021
|
Anne Mc George |
BUY
Grant, award, or other acquisition
|
Direct |
21,067
+26.51%
|
-
|
|
Jun 03
2021
|
Steven J Shulman |
BUY
Grant, award, or other acquisition
|
Direct |
26,685
+0.77%
|
-
|
|
May 04
2021
|
Gyasi C. Chisley |
BUY
Grant, award, or other acquisition
|
Direct |
44,150
+50.0%
|
-
|
|
Mar 19
2021
|
Joseph P Greskoviak |
BUY
Grant, award, or other acquisition
|
Direct |
15,883
+22.99%
|
-
|
|
Feb 16
2021
|
John W. Kalix Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,415,093
+50.0%
|
-
|
|
Jan 28
2021
|
Sean Banerjee Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
88,670
+27.27%
|
-
|
|
Jan 28
2021
|
Robert Jason Hallock Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
88,670
+50.0%
|
-
|
|
Jan 28
2021
|
Eunice Kim General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
88,670
+50.0%
|
-
|
|
Jan 28
2021
|
Christopher K Knibb Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
121,130
+50.0%
|
-
|
|
Jan 28
2021
|
Hai Tran President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
221,675
+24.59%
|
-
|
|
Jan 05
2021
|
Barbara Peterson Byrne |
BUY
Grant, award, or other acquisition
|
Direct |
37,320
+50.0%
|
-
|
|
Jan 05
2021
|
Thomas J. Carella |
BUY
Grant, award, or other acquisition
|
Direct |
37,320
+34.93%
|
-
|
|
Jan 05
2021
|
Joseph P Greskoviak |
BUY
Grant, award, or other acquisition
|
Direct |
37,320
+50.0%
|
-
|
|
Jan 05
2021
|
Amr Kronfol |
BUY
Grant, award, or other acquisition
|
Direct |
37,320
+31.74%
|
-
|
|
Jan 05
2021
|
Anne Mc George |
BUY
Grant, award, or other acquisition
|
Direct |
37,320
+50.0%
|
-
|
|
Jan 05
2021
|
Steven J Shulman |
BUY
Grant, award, or other acquisition
|
Direct |
37,320
+2.16%
|
-
|
|
Oct 30
2020
|
Charles J. Ditkoff Former President |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,375,000
+46.3%
|
-
|
|
Oct 30
2020
|
Steven J Shulman |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,375,000
+46.3%
|
-
|
|
Oct 30
2020
|
Hcmc Sponsor LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
4,375,000
+46.3%
|
-
|
|
Oct 30
2020
|
Sean Banerjee Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
147,786
+35.44%
|
-
|
|
Oct 30
2020
|
Thomas J. Carella |
BUY
Grant, award, or other acquisition
|
Direct |
32,204
+34.16%
|
-
|
|
Oct 30
2020
|
Amr Kronfol |
BUY
Grant, award, or other acquisition
|
Direct |
42,939
+34.16%
|
-
|
|
Oct 30
2020
|
Hai Tran President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
458,066
+35.44%
|
-
|
|
Oct 30
2020
|
Alyeska Investment Group, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
400,000
+0.78%
|
$3,600,000
$9.08 P/Share
|
|
Oct 30
2020
|
Alyeska Investment Group, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
200,000
+0.78%
|
$1,800,000
$9.08 P/Share
|
|
Oct 27
2020
|
Glazer Capital, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
3,039,517
+100.0%
|
$30,395,170
$10.06 P/Share
|
|
Oct 27
2020
|
Glazer Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
41,483
-1.35%
|
$414,830
$10.09 P/Share
|
|
Oct 13
2020
|
Alyeska Investment Group, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
55,148
+0.44%
|
$551,480
$10.01 P/Share
|
|
Oct 13
2020
|
Alyeska Investment Group, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
27,574
+0.44%
|
$275,740
$10.01 P/Share
|
|
Oct 12
2020
|
Alyeska Investment Group, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
344,852
+2.72%
|
$3,448,520
$10.0 P/Share
|